1437 studies found for:    "Anticoagulants"
Show Display Options
Rank Status Study
1 Active, not recruiting D-dimer to Select Patients With First Unprovoked Venous Thromboembolism Who Can Have Anticoagulants Stopped at 3 Months
Conditions: Deep Vein Thrombosis;   Pulmonary Embolism
Interventions: Other: Discontinue anticoagulant therapy (Negative d-dimer);   Other: Continue on anticoagulant therapy (positive d-dimer)
2 Completed Anticoagulant Clinics and Vitamin K Antagonists
Condition: Blood Coagulation Disorders
Intervention: Drug: Anticoagulant (warfarin, acenocoumarol, fluindione)
3 Completed Assays for and Reversal of New Anticoagulants
Conditions: Atrial Fibrillation;   Osteoarthritis of the Knee;   Osteoarthritis of the Hip
Intervention:
4 Not yet recruiting Influence of ABCB1 Polymorphisms on Plasma Concentrations of New Oral Anticoagulants in Case of Serious Adverse Events
Conditions: Anticoagulants;   Thromboembolism;   Hemorrhage
Interventions: Other: Measurement of Plasma Concentrations of NOACs;   Genetic: Identification of ABCB1 polymorphisms coding for P-gp
5 Recruiting Evaluation of the Duration of Therapy for Thrombosis in Children
Condition: Venous Thrombosis
Interventions: Other: Shortened duration (6 weeks) of anticoagulant therapy;   Other: Conventional duration (3 months) of anticoagulant therapy;   Other: No Intervention
6 Completed Comparative Analysis of Injectable Anticoagulants for Thromboprophylaxis Post Cancer-related Surgery
Condition: Thrombosis, Venous
Interventions: Drug: dalteparin;   Drug: enoxaparin;   Drug: fondaparinux;   Drug: unfractionated heparin
7 Not yet recruiting SILENT - Subclinical AtrIal FibrilLation and StrokE PreveNtion Trial
Condition: Atrial Fibrillation
Intervention: Drug: anticoagulant by physician criteria
8 Recruiting Patent Foramen Ovale Closure or Anticoagulants Versus Antiplatelet Therapy to Prevent Stroke Recurrence
Conditions: Ischemic Stroke;   Patent Foramen Ovale;   Atrial Septal Aneurysm;   Migraine
Interventions: Drug: aspirin;   Drug: Antivitamins K;   Device: Devices for PFO closure
9 Completed Prevention of the Hepatic Sinusoidal Obstruction Syndrome by Means of Anticoagulants
Conditions: Sinusoidal Obstruction Syndrome;   Colorectal Liver Metastases
Intervention:
10 Recruiting Rhythm Evaluation for AntiCoagulaTion With COntinuous Monitoring
Condition: Atrial Fibrillation
Intervention: Drug: Non-coumadin Oral Anticoagulant
11 Completed Anticoagulant and Antiplatelet Agents in Patients Undergoing Vitreoretinal Surgery
Condition: Retinal Detachment
Intervention:
12 Not yet recruiting Evaluation of the Use of Apixaban in Prevnetion of Thromboembolic Disease in Patients With Myeloma Trated With iMiDs
Conditions: Myeloma;   Venous Thromboembolism
Intervention: Drug: Apixaban
13 Recruiting Clinical Decision Rule Validation Study to Predict Low Recurrent Risk in Patients With Unprovoked Venous Thromboembolism
Condition: Idiopathic Venous Thromboembolism
Intervention: Other: Application of the"Men continue and HER DOO2" rule
14 Unknown  Anticoagulant Treatments and Percutaneous Coronary Angioplasty
Condition: Coronary Artery Disease
Interventions: Drug: clopidogrel + aspirin;   Drug: heparin + clopidogrel + aspirin;   Drug: enoxaparin + clopidogrel + aspirin;   Drug: bivalirudin + clopidogrel + aspirin
15 Recruiting Outpatient Treatment of Low-Risk Venous Thromboembolism With Target Specific Anticoagulant
Condition: Venous Thromboembolism
Intervention:
16 Recruiting Benefits of a Comprehensive Patient Education on Oral Anticoagulant Compared to Conventional Hospital Education
Condition: Cardiac Surgery
Interventions: Behavioral: VKA (antivitamin K) education;   Behavioral: conventional hospital education
17 Completed Prospective Evaluation of Bleeding Risk of Anticoagulant and Anti-platelet Therapy
Condition: Bleeding
Intervention: Drug: Antithrombotics
18 Recruiting Observatory of Invasive Procedures and Bleeding in Patients Treated With New Oral Anticoagulants
Conditions: Venous Thromboembolism;   Atrial Fibrillation
Intervention: Other: complications and compliance with GIHP recommendations
19 Suspended Safety Study of Recombinant NAPc2 to Prevent Tumor Progression and Metastases in Metastatic Colon Cancer
Condition: Colon Cancer
Intervention: Drug: recombinant nematode anticoagulant protein c2 (rNAPc2)
20 Completed Residual Vein Thrombosis Establishes the Optimal Duration of Oral Anticoagulants
Condition: Deep Vein Thrombosis
Intervention: Drug: Warfarin

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
Indicates status has not been verified in more than two years